{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:09:19Z","timestamp":1793347759945,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304280"],"award-info":[{"award-number":["82304280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118123","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:52:00Z","timestamp":1757170320000},"page":"118123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Discovery of novel indazole derivatives as type \u2160 PRMTs inhibitors for the treatment of triple-negative breast cancer"],"prefix":"10.1016","volume":"300","author":[{"given":"Qiangsheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5721-5294","authenticated-orcid":false,"given":"Xianli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejmech.2025.118123_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","article-title":"Protein arginine methylation: from enigmatic functions to therapeutic targeting","volume":"20","author":"Wu","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118123_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41580-019-0143-1","article-title":"The roles of DNA, RNA and histone methylation in ageing and cancer","volume":"20","author":"Michalak","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118123_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05531-6","article-title":"Lysine and arginine methylation of transcription factors","volume":"82","author":"Giaimo","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"20","key":"10.1016\/j.ejmech.2025.118123_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183391","article-title":"Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges","volume":"134","author":"Gold","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118123_bib5","first-page":"264","article-title":"Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: current progress and novel strategies","author":"Li","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118123_bib6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/13543776.2025.2483399","article-title":"An updated patent review of EZH2 inhibitors (2024-present)","volume":"35","author":"Wan","year":"2025","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.118123_bib7","first-page":"178","article-title":"Focus on the classical and non-classical functions of EZH2: guide the development of inhibitors and degraders","author":"Zhang","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118123_bib8","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1016\/j.molcel.2021.09.011","article-title":"Cellular pathways influenced by protein arginine methylation: implications for cancer","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2025.118123_bib9","first-page":"221","article-title":"Protein arginine methyltransferases (PRMTs): orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance","author":"Gao","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118123_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101016","article-title":"Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance","volume":"72","author":"Zhu","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2025.118123_bib11","first-page":"342","article-title":"Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: asthma, COPD, lung cancer, PF, and PH","author":"Zhou","year":"2024","journal-title":"Life Sci."},{"issue":"13","key":"10.1016\/j.ejmech.2025.118123_bib12","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1021\/acs.jmedchem.3c00250","article-title":"Targeting arginine methyltransferase PRMT5 for cancer therapy: updated progress and novel strategies","volume":"66","author":"Zheng","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118123_bib13","first-page":"283","article-title":"PRMT7 in cancer: structure, effects, and therapeutic potentials","author":"Yang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118123_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107859","article-title":"Medicinal chemistry insights into PRMT5 inhibitors","volume":"153","author":"Jiao","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118123_bib15","first-page":"244","article-title":"Medicinal chemistry strategies targeting PRMT5 for cancer therapy","author":"Fu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118123_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115484","article-title":"PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms","volume":"44","author":"Xia","year":"2025","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118123_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52507-y","article-title":"PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma","volume":"15","author":"Walton","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118123_bib18","first-page":"267","article-title":"Overview of the development of protein arginine methyltransferase modulators: achievements and future directions","author":"Tong","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118123_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ccell.2019.05.014","article-title":"Anti-tumor activity of the type I PRMT inhibitor, GSK3368715, synergizes with PRMT5 inhibition through MTAP loss","volume":"36","author":"Fedoriw","year":"2019","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118123_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1021\/acschembio.5b00839","article-title":"A potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases","volume":"11","author":"Eram","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118123_bib21","doi-asserted-by":"crossref","first-page":"8888","DOI":"10.1021\/acs.jmedchem.7b01134","article-title":"Development of potent type I protein arginine methyltransferase (PRMT) inhibitors of leukemia cell proliferation","volume":"60","author":"Wang","year":"2017","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118123_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1021\/acs.jcim.1c01100","article-title":"Identification, synthesis, and biological evaluations of potent inhibitors targeting type I protein arginine methyltransferases","volume":"62","author":"Li","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"23","key":"10.1016\/j.ejmech.2025.118123_bib23","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1074\/jbc.M401853200","article-title":"Small molecule regulators of protein arginine methyltransferases","volume":"279","author":"Cheng","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118123_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41416-023-02276-0","article-title":"Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors","volume":"129","author":"El-Khoueiry","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118123_bib25","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1021\/jm401884z","article-title":"Diamidine compounds for selective inhibition of protein arginine methyltransferase 1","volume":"57","author":"Yan","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118123_bib26","article-title":"Design and synthesis of novel PRMT1 inhibitors and investigation of their effects on the migration of cancer cell","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2025.118123_bib27","doi-asserted-by":"crossref","first-page":"16650","DOI":"10.1021\/acs.jmedchem.1c01308","article-title":"Structure-based discovery of potent CARM1 inhibitors for solid tumor and cancer immunology therapy","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118123_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18446-z","article-title":"Identification of a CARM1 inhibitor with potent and activity in preclinical models of multiple myeloma","volume":"7","author":"Drew","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118123_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acsmedchemlett.5b00071","article-title":"Aryl pyrazoles as potent inhibitors of arginine methyltransferases: identification of the first PRMT6 tool compound","volume":"6","author":"Mitchell","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118123_bib30","first-page":"247","article-title":"Design, synthesis and evaluation of antitumor activity of selective PRMT6 inhibitors","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2025.118123_bib31","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1021\/acs.jmedchem.6b01033","article-title":"Discovery of a potent, selective, and cell-active dual inhibitor of protein arginine methyltransferase 4 and protein arginine methyltransferase 6","volume":"59","author":"Shen","year":"2016","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118123_bib32","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1021\/acs.jmedchem.3c02265","article-title":"Development of (2-(Benzyloxy)phenyl)methanamine derivatives as potent and selective inhibitors of CARM1 for the treatment of melanoma","volume":"67","author":"Liu","year":"2024","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2025.118123_bib33","doi-asserted-by":"crossref","first-page":"15931","DOI":"10.1021\/acs.jmedchem.4c00490","article-title":"Structure, function, and activity of small molecule and peptide inhibitors of protein arginine methyltransferase 1","volume":"67","author":"Hendrickson-Rebizant","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118123_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116288","article-title":"Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy","volume":"269","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118123_bib35","article-title":"PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling","volume":"13","author":"Yao","year":"2021","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118123_bib36","article-title":"PRMT6-mediated H3R2me2a guides Aurora B to chromosome arms for proper chromosome segregation","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118123_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107439","article-title":"Discovery of a first-in-class degrader for the protein arginine methyltransferase 6 (PRMT6)","volume":"148","author":"Yang","year":"2024","journal-title":"Bioorg. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:59:12Z","timestamp":1772830752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"alternative-id":["S0223523425008888"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118123","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel indazole derivatives as type \u2160 PRMTs inhibitors for the treatment of triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118123"}}